NCT04734262 2023-11-18
SPARK
Fudan University
Phase 2 Unknown
Clinical Trials
4 trialsNCT03567720 2023-06-01
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
OncoSec Medical Incorporated
Phase 2 Unknown
NCT04745975 2022-04-20
Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer
Fudan University
Phase 2 Unknown
NCT04676997 2020-12-21
Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)
Shandong Cancer Hospital and Institute
Phase 2 Unknown